BRIEF published on 03/27/2025 at 19:17, 1 month 4 days ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
BRIEF published on 03/27/2025 at 19:17, 1 month 4 days ago Advicenne annonce une croissance solide et des projets futurs pour 2025 Amélioration Des Flux De Trésorerie Perspectives 2025 Résultats Financiers D'Advicenne Croissance Des Ventes De Sibnayal Progrès Réglementaires ADV7103
PRESS RELEASE published on 03/27/2025 at 19:12, 1 month 4 days ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
PRESS RELEASE published on 03/27/2025 at 19:12, 1 month 4 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne annonce ses résultats annuels 2024 avec un chiffre d'affaires en hausse de 9,4% grâce à Sibnayal® en Europe; avancées réglementaires majeures aux Etats-Unis Chiffre D'affaires Résultats Annuels États-Unis Advicenne Sibnayal
BRIEF published on 10/01/2024 at 07:05, 6 months 30 days ago Advicenne progresse aux États-Unis avec des avis positifs de la FDA sur ADV7103 FDA Advicenne ADV7103 ATRd Cystinurie
BRIEF published on 10/01/2024 at 07:05, 6 months 30 days ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 6 months 30 days ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
PRESS RELEASE published on 10/01/2024 at 07:00, 6 months 30 days ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 11 months 16 days ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
BRIEF published on 05/15/2024 at 09:07, 11 months 16 days ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
Published on 05/01/2025 at 05:25, 1 hour 1 minute ago GLG Life Tech Corporation Reports 2024 Annual & Fourth Quarter Financial Results
Published on 05/01/2025 at 05:00, 1 hour 26 minutes ago Alphinat Announces a Profit of $51,824 for Fiscal Year Ended August 31, 2024
Published on 05/01/2025 at 04:25, 2 hours 1 minute ago Alphinat Announces a Profit of $84,870 for Fiscal Year Ended August 31, 2023
Published on 05/01/2025 at 02:00, 4 hours 26 minutes ago EQ Inc. Reports Profitable Fourth Quarter and 2024 Year End Financial Results
Published on 05/01/2025 at 00:00, 6 hours 26 minutes ago Tecogen Announces Uplist to NYSE American Stock Exchange
Published on 04/30/2025 at 23:30, 6 hours 56 minutes ago EEII AG: Ad-Hoc announcement pursuant to Art. 53 Listing Rules: EEII AG 2024 Annual Results
Published on 04/30/2025 at 22:43, 7 hours 43 minutes ago Assemblée générale ordinaire d’Espace Real Estate Holding AG
Published on 04/30/2025 at 21:15, 9 hours 11 minutes ago voxeljet AG announces financial restructuring with StaRUG procedure after general meeting rejects approval of the sale of the business to Anzu
Published on 04/30/2025 at 21:00, 9 hours 26 minutes ago Northern Data Group issues Business and Operational Update
Published on 04/30/2025 at 20:40, 9 hours 45 minutes ago EQS-Adhoc: Northern Data Group Updates 2025 Guidance and Provides New Guidance Framework
Published on 04/30/2025 at 19:14, 11 hours 11 minutes ago Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 11 hours 12 minutes ago Solocal - Press Release - Filing of 2024 URD
Published on 04/30/2025 at 19:14, 11 hours 12 minutes ago Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 11 hours 30 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025
